Helicobacter pylori stool antigen test in children with recurrent abdominal pain disease diagnosis and treatment of.docVIP

 PAGE \* MERGEFORMAT 6 Helicobacter pylori stool antigen test in children with recurrent abdominal pain disease diagnosis and treatment of [Abstract] Objective To evaluate the Helicobacter pylori stool antigen test (HpSA in children with recurrent abdominal pain, disease diagnosis and treatment of value. Methods consistent with the clinical diagnosis of recurrent abdominal pain in 65 cases of children receiving the standard 13C-urea breath test (13C -UBT) examination more than 2 days to collect stool samples of children, application of principle of enzyme immunoassay HpSA test; with 13C-UBT as the diagnostic criteria. HpSA results of the sensitivity of detection and diagnosis of Hp infection was 87.1%, specificity 91.18%, positive predictive value was 93.1%, negative predictive value 88.87% and 90.77% accuracy. Conclusions In children with recurrent abdominal pain, diagnosis and treatment, HpSA test is a simple, non-invasive, rapid and effective screening method. [Keywords:] children with recurrent abdominal pain, stool, Helicobacter pylori Recurrent abdominal pain (recurrent abdominal pain, RAP) is a common childhood diseases of digestive system, and more recurrent, long-lasting, often after repeated treatment given to spasm or poor efficacy of anthelmintic treatment. Repeated medical , leading to concern and anxiety in children and their parents, while increasing financial burden on parents. through the simple and effective method to determine the cause of RAP is very important. This study aimed to investigate HpSA detection methods in the diagnosis and treatment of children with recurrent abdominal pain in the clinical diagnostic value. 1 Subjects and methods 1.1 The object of study in March 2005 ~ March 2008 65 cases of out-patients, diagnostic criteria are in line with RAP, aged 4 to 15 years old, 30 males and 35 female. 1.2 RAP diagnostic criteria (1) recurrent abdominal pain more than 3 months; (2) non-specific intermittent episodes